Sage Therapeutics' postpartum depression drug succeeds in study

July 12 (Reuters) - Sage Therapeutics Inc said its

experimental drug to treat severe postpartum depression met the

main goal of alleviating symptoms more than a placebo in a

mid-stage study.

Read more